Glaucoma 360: Drug delivery contact lens technology
July 17th 2020ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.
Read More
Glaucoma 360: Accessible glaucoma care in 1 second (BELKIN Laser)
July 12th 2020ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).
Read More